Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05821634 · ClinicalTrials.gov registry record · NA
Personalizing Treatment Delivery
A NA study of Anxiety Disorders and Symptoms and PTSD and Trauma-related Symptoms, sponsored by Rutgers, The State University of New Jersey.
- Recruiting
- Registry status
- NA
- Development phase
- 81
- Enrollment target
- 1
- Study location
NCT05821634 is a NA study of Anxiety Disorders and Symptoms and PTSD and Trauma-related Symptoms that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 81 participants, below the 128-participant average among 9 other Anxiety Disorders and Symptoms trials with a reported enrollment target (37% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05821634, a NA study of Anxiety Disorders and Symptoms and PTSD and Trauma-related Symptoms, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.
- RECRUITING
- Registry status
- NA
- Development phase
- 81 participants
- Enrollment target
- 1
- Study location
Study Summary
Anxiety and anxiety-related disorders frequently co-occur with alcohol use problems resulting in an enormous humanitarian and economic cost to society. The proposed research will use digital technology to examine person-specific risk factors predicting problematic alcohol use in individuals vulnerable to anxiety and anxiety-related disorders and will use this information to design a personalized intervention for individuals seeking psychological treatment. Results from this research will integrate output from novel and innovative digital technology methods into psychotherapy, advancing research on personalized treatment and prevention efforts.
Conditions Studied
Interventions
- BEHAVIORAL Personalized intervention condition: Cognitive behavioral therapy skills
- BEHAVIORAL Therapeutic control condition: Cognitive behavioral therapy skills
- BEHAVIORAL Tracking control condition: Supportive counseling
Study Locations (1)
New Jersey
- Rutgers Robert Wood Johnson Medical School - Piscataway
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2024-10-21 |
| Est. Completion | 2027-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05821634
The ClinicalTrials.gov registry entry for NCT05821634 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 128-participant average among 9 other Anxiety Disorders and Symptoms trials with a reported enrollment target (37% lower). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Anxiety Disorders and Symptoms appearing as the primary indexed condition, and to 3 interventions - of which Personalized intervention condition: Cognitive behavioral therapy skills is the first listed.
NCT05821634 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT05821634 about?
NCT05821634 is a clinical study titled "Personalizing Treatment Delivery". Anxiety and anxiety-related disorders frequently co-occur with alcohol use problems resulting in an enormous humanitarian and economic cost to society. The proposed research will use digital technology to examine person-specific risk factors predicting problematic alcohol use in individuals vulnerab...
What is the current status of trial NCT05821634?
This trial is currently recruiting. It is a NA study. The enrollment target is 81 participants. The study started on 2024-10-21. Estimated completion is 2027-04-01.
What conditions does trial NCT05821634 study?
This clinical trial studies the following conditions: Anxiety Disorders and Symptoms, PTSD and Trauma-related Symptoms, Alcohol; Use, Problem; Alcohol Use Disorder.
What interventions are being tested in trial NCT05821634?
The interventions under investigation include: Personalized intervention condition: Cognitive behavioral therapy skills (BEHAVIORAL), Therapeutic control condition: Cognitive behavioral therapy skills (BEHAVIORAL), Tracking control condition: Supportive counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT05821634?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05821634 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety Disorders and Symptoms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Family Spirit Strengths
RECRUITING · NA
-
Mobile CBT for Middle Aged and Older Adults
RECRUITING · NA
-
Personalized Mobile Cognitive Behavioral Therapy Application
RECRUITING · NA
-
Evaluating a Virtual Mentoring Program Plus Mental Health Videos for Teens
ACTIVE NOT RECRUITING · NA
-
Mobile Cognitive Behavior Therapy Targeting Anxiety Disorders
COMPLETED · NA
-
Adapting Project UPLIFT for Blacks in Georgia
COMPLETED · NA
Explore more on PlainTrial
Anxiety Disorders and Symptoms
All registered trials for this condition
PTSD and Trauma-related Symptoms
All registered trials for this condition
New Jersey
All trials with a study site in New Jersey
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.